Rana Al-Hallaq
InvestorVice President, WWBD / Partner at Pfizer Venture Investments
New York City
Writes $100K – $15M checks · typically $10M
Find your path to Rana
300 people in our graph share verified history with Rana — schools, employers, funds. One of them is your warm intro.
Uri LopatinunlockedRana: together at National Institutes of Health (2002–2007)
×3Rana: together at Georgetown
Rana: together at Arkuda Therapeutics
Rana: together at Montis Biosciences
About
Partner and Head of Operations at Pfizer Ventures responsible for identifying, evaluating, and managing equity investments aligned with Pfizer's strategic directions, including current oversight of eight portfolio companies and several fund investments. Brings expertise from clinical development and business development roles at Pfizer and Allergan, with a background in neuroscience research.
Experience
- PfizerVice President, Worldwide Business Development & Partner and Head of Operations, Pfizer Venturescurrent2025 — presentNew York, United States
- PfizerPartner, Pfizer Ventures and Executive Director, Pfizer Worldwide Business Development2021 — 2025New York, New York, United States
- PfizerSenior Director and Partner, Pfizer Ventures2020 — 2021New York, New York, United States
- PfizerSenior Director and Principal, Pfizer Ventures2018 — 2020Greater New York City Area
- PfizerDirector Business Development2016 — 2018
- PfizerEarly Candidate Clinical Lead2015 — 2016New York City
- Enara BioBoard Membercurrent2024 — present
- ReCode TherapeuticsDirector Board Of Directorscurrent2021 — presentMenlo Park, Calif. and Dallas, Texas
- Vivet TherapeuticsDirector Board Of Directorscurrent2021 — presentParis, Île-de-France, France
- RefleXion MedicalDirector Board Of Directorscurrent2021 — presentHayward, California, United States
- Montis BiosciencesDirector Board Of Directorscurrent2020 — presentLeuven, Flemish Region, Belgium
- NY BIODirector Board Of Directorscurrent2019 — presentNew York, New York, United States
- Autifony TherapeuticsDirector Board Of Directorscurrent2019 — presentStevenage, England, United Kingdom
- Blade TherapeuticsDirector Board Of Directorscurrent2019 — presentSan Francisco, California, United States
- Triplet TherapeuticsDirector Board Of Directors2021 — 2025Cambridge, Massachusetts, United States
- Jnana TherapeuticsObserver Board of Directors2021 — 2025Boston, Massachusetts, United States
- Arkuda TherapeuticsObserver Board of Directors2019 — 2025Cambridge, Massachusetts, United States
- Mitokinin IncDirector Board Of Directors2019 — 2025San Francisco, California, United States
- Forest LaboratoriesSenior Manager, Business Development2012 — 2015
- Forest Research InstituteClinical Scientist2008 — 2012
- National Institutes of HealthVisiting Research Fellow2002 — 2008
Skills & more
Oncology25Biotechnology23Drug Discovery24Clinical Research16Pharmacology5Immunology6Biostatistics1Biochemistry10Cell Culture4ELISA1Genetics4Pharmaceutical Industry33
Languages Arabic · French · Spanish
From Rana's professional profile.
Deals · 1
ReflexionmedicalBoard seat
via Pfizer Venture Investments · filed Mar 2022 · $110M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Pfizer Venture Investments
Ama Amoah
Finance Director, Business Development at Pfizer Venture Investments
Andrew J. Muratore
Vice President & Chief Counsel, M&A and Licensing at Pfizer Venture Investments
Anthony Barry
Executive Director, WWBD / Partner at Pfizer Venture Investments
Artem Smirnov
Partner at Xora
Boyoon Choi
Senior Corporate Counsel at Pfizer Venture Investments
Carlos Murillo
Presidente Pfizer España at Taram Capital
Christopher O'Donnell
Partner at Pfizer Venture Investments
Gillian Akai
Senior Vice President, General Counsel, Communications and Corporate Secretary at Maple Leaf Foods strategic venture activity
Network1
Investors connected to Rana in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Rana Al-Hallaq?
- Partner and Head of Operations at Pfizer Ventures responsible for identifying, evaluating, and managing equity investments aligned with Pfizer's strategic directions, including current oversight of eight portfolio companies and several fund investments. Brings expertise from clinical development and business development roles at Pfizer and Allergan, with a background in neuroscience research.
- Where does Rana Al-Hallaq work?
- Rana Al-Hallaq is Vice President, WWBD / Partner at Pfizer Venture Investments.
- What check size does Rana Al-Hallaq write?
- Rana Al-Hallaq typically writes checks of $100K – $15M.
- What boards does Rana Al-Hallaq sit on?
- Rana Al-Hallaq holds tracked board seats at Reflexionmedical.
- Where did Rana Al-Hallaq go to school?
- Rana Al-Hallaq studied at Georgetown University (PhD, Neuroscience); Hamilton College (BA, Biology).
Same school
Also attended Georgetown University631
Trae StephensPartner at Founders Fund and co-founder of AndurilLuciana LixandruPartner at Sequoia CapitalKatherine BoyleGeneral Partner at Andreessen Horowitz (American Dynamism)Tobi CokerDeal Partner at Felicis VenturesAna AndreescuInvestor at Index VenturesDiana BerishaInvestor at Spark Capital
%20(1)%20(1).png)
+ 625 more
Also attended Hamilton College67
Dan BartusPartner, Head of Research at Felicis VenturesDavid BloodFounding Partner and Senior Partner at Generation Investment ManagementDaniel GlassManaging Director, Global Market Research at Deerfield Management CompanySarah SommerCo-Founder and Partner at Level EquityJosh LabonteSenior Associate at Level EquityGeoff OblakGeneral Partner at Data Point Capital
+ 61 more
Shared employers
Also worked at Pfizer229
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesMichael TaylorOperating Partner at Mission Biocapital
+ 223 more
Also worked at Enara Bio1
Also worked at Vivet Therapeutics3
Also worked at Forest Laboratories9
Jayson RiegerManaging Partner at PBM CapitalJeffrey M. JonasPartner at Cure VenturesJulia StephanusPartner at Borealis VenturesIvan GergelManaging Partner and Chief Medical Officer at New Rhein Healthcare Investors, LLCStephen LePartner at MBK PartnersKristen RooneyHead of Business Development at Third Prime
+ 3 more